
RIBOLDI ILARIA
Pubblicazioni
Cavaleri, D., Crocamo, C., Riboldi, I., Guzzi, P., Bartoli, F., Carrà, G. (2026). Complete blood count-based inflammation indexes and symptom severity in people with bipolar disorder: an analysis based on structural equation modelling. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 276(2), 561-572 [10.1007/s00406-025-02129-2]. Dettaglio
Bartoli, F., Cavaleri, D., Riboldi, I., Capogrosso, C., Carrà, G. (2025). Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies. PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 18, 1455-1469 [10.2147/prbm.s474513]. Dettaglio
Crocamo, C., Palpella, D., Cavaleri, D., Nasti, C., Piacenti, S., Morello, P., et al. (2025). Digital health interventions for mental health disorders: an umbrella review of meta-analyses of randomised controlled trials. THE LANCET. DIGITAL HEALTH, 7(8) [10.1016/j.landig.2025.100878]. Dettaglio
Riboldi, I., Cavaleri, D., Morreale, M., Crocamo, C., Bartoli, F., Carrà, G. (2025). Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysis. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 15, 1-13 [10.1177/20451253251385730]. Dettaglio
Cavaleri, D., Riboldi, I., Bartoli, F. (2025). The Promise of Long-acting Injectable Antipsychotics for the Treatment of Bipolar I Disorder: The Role of Manic Predominance. ACTAS ESPAÑOLAS DE PSIQUIATRÍA, 53(5), 1157-1159 [10.62641/aep.v53i5.1976]. Dettaglio